AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
-4.08%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$230M
AUM Growth
+$230M
(-12%)
Cap. Flow
-$6.83M
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
CERo Therapeutics
CERO
|
$477K |
Top Sells
| 1 |
Beam Therapeutics
BEAM
|
$7.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Beam Therapeutics
BEAM
$1.65B
| $113M | 48.91% |
4,540,132
-294,521
| -6% | -$7.3M |
|
|
RAPP
2
Rapport Therapeutics
RAPP
$597M
| $66.1M | 28.73% |
3,728,738
| – | – |
|
3
Erasca
ERAS
$454M
| $27.7M | 12.05% |
11,055,554
| – | – |
|
|
VERV
4
DELISTED
Verve Therapeutics
VERV
| $11.3M | 4.92% |
2,008,809
| – | – |
|
5
Gossamer Bio
GOSS
$589M
| $7.29M | 3.17% |
8,055,916
| – | – |
|
|
OMIC
6
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $2.46M | 1.07% |
126,630
| – | – |
|
7
Q32 Bio
QTTB
$20.9M
| $1.1M | 0.48% |
320,482
| – | – |
|
|
UBX
8
DELISTED
Unity Biotechnology
UBX
| $981K | 0.43% |
1,004,817
| – | – |
|
|
9
CERo Therapeutics
CERO
$8.92M
| $564K | 0.24% |
9,393,561
+7,949,265
| +550% | +$477K |
|